Skip to main content

Table 1 Characteristics of Subjects at enrollment*

From: No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial

Characteristics Placebo (n = 7) Epoprostenol (n = 7)
Male gender 4 (57) 4 (57)
Age, yr 54.4 (19.9) 55.3 (18.2)
Weight, kg 78.9 (11.2) 74.0 (9.7)
RVED, cm 4.1 (0.84) 4.1 (0.83)
Systolic PAP, mmHg 47 (10.6) 57 (13.9)
Right ventricle free wall diameter, mm 6.1 (0.7) 5.9 (0.9)
NT-proBNP, pg/ml 1467 (39-8549) 3885 (270-12339)
Troponin T, ng/ml 0.01 (0.01-0.13) 0.03 (0.01-0.12)
PaO2, mmHg 85 (14) 74 (12)
  1. Definition of abbreviations: PAP = pulmonary artery pressure; RVED = right ventricular end-diastolic diameter; PaO2 = partial arterial oxygen pressure
  2. *Data are presented as No. (%) or mean (SD). NT-proBNP and troponin T are presented as median (range)